Quality of Life (QOL) improvement following catheter-based autologous bone marrow mononuclear cell transplantation (ABM-MCT)

Table 2 :

Medical Outcomes Study Short Form-36	Baseline	8 weeks	P	24 weeks	P
BP	39 ± 22	79 ± 27	0.0014	68 ± 30	0.03
MH	58 ± 21	74 ± 19	0.02	77 ± 20	0.02
GH	61 ± 19	77 ± 16	0.03	81 ± 21	0.05
PF	43 ± 26	68 ± 24	0.009	71 ± 26	0.03
RE	39 ± 49	58 ± 43	0.27	92 ± 15	0.06
RP	35 ± 42	65 ± 42	0.03	84 ± 27	0.06
SF	68 ± 26	74 ± 21	0.34	86 ± 14	0.04
VI	57 ± 22	74 ± 18	0.02	76 ± 19	0.08

ISSN: 1364-8535